Skip Navigation

European Heart Journal 2001 22(18):1682-1690; doi:10.1053/euhj.2000.2541
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Higgins, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Patients, families and populations at high risk for coronary heart disease

M Higginsf1

Departments of Epidemiology and Internal Medicine, University of Michigan, Michigan, USA

revised November 20, 2000; accepted November 22, 2000

Key Words: Epidemiology, prevention, risk factors, risk appraisal

f1 Correspondence: Dr M. Higgins, University of Michigan, Departments of Epidemiology and Internal Medicine, 252 Indian River Place, Ann Arbor, MI 48104, U.S.A.

References

  1. Pearson TA, McBride PE, Miller NH, Smith SC. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service. J Am Coll Cardiol. 1996;27:1039–1047[CrossRef][Web of Science][Medline]
  2. Circulation. 1995;92:2–4
  3. D'Agostino RB, Russell MW, Huse DM. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139:272–281[Web of Science][Medline]
  4. Wallis EJ, Ramsay LE, Haq IU. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ. 2000;320:671–676[Abstract/Free Full Text]
  5. Pyörälä K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994;10:1300–1331
  6. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Blood Press. 1998;5–6:262–269
  7. BMJ. 2000;320:705–709[Free Full Text]
  8. Circulation. 1994;89:1333–1445[Medline]
  9. Ridker PM. Novel risk factors and markers for coronary disease. Adv Intern Med. 2000;45:391–418[Medline]
  10. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843[Abstract/Free Full Text]
  11. Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am. 2000;84:149–161[CrossRef][Web of Science][Medline]
  12. Bostom AG, Silbershatz H, Rosenberg IH. Nonfasting plasma total homocysteine levels and all cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999;159:1077–1080[Abstract/Free Full Text]
  13. LaRosa J, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999;282:2340–2346[Abstract/Free Full Text]
  14. Arch Intern Med. 1998;157:2413–2446
  15. J Hypertens. 1999;17:151–183[Web of Science][Medline]
  16. Ornish D, Scherwitz LW, Billings JH. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280:2001–2007[Abstract/Free Full Text]
  17. Stampfer M, Hu F, Manson J, Rimm E, Willett W. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16–22[Abstract/Free Full Text]
  18. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779–785[Abstract/Free Full Text]
  19. Hunt SC, Cook NR, Oberman A. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension. 1998;32:393–401[Abstract/Free Full Text]
  20. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism. 1993;42:895–901[CrossRef][Web of Science][Medline]
  21. Kuivenhoven JA, Jukema JW, Zwinderman AH. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med. 1998;338:86–93[Abstract/Free Full Text]
  22. Batey DM, Kaufmann PG, Raczynski JM. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). Ann Epidemiol. 2000;10:45–58[CrossRef][Web of Science][Medline]
  23. N Engl J Med. 2000;342:154–160[Abstract/Free Full Text]
  24. Hulley S, Grady D, Bush T. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605–613[Abstract/Free Full Text]
  25. Goldman L, Coxson P, Hunink MG. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. J Am Coll Cardiol. 1999;34:768–776[Abstract/Free Full Text]
  26. Institute of Medicine, To Err Is Human: Building a Safer Health System. Machine-readable data, Washington, D.C. National Academy of Sciences, National Academy Press, 1999
  27. McDonald CJ, Weiner M, Hui SL. Deaths due to medical errors are exaggerated in institute of medicine report. JAMA. 2000;284:93–95[Free Full Text]
  28. Leape LL. Institute of Medicine figures are not exaggerated. JAMA. 2000;284:95–97[Free Full Text]
  29. US Department of Health and Human Services, Healthy People 2010, 2000
  30. Epstein FH, Napier JA, Block WD. The Tecumseh Study. Design, progress and perspectives. Arch Environ Health. 1970;21:402–407[Web of Science][Medline]
  31. Last JM. A dictionary of epidemiology. New York: Oxford University Press; 1995.
  32. Higgins M, Province M, Heiss G. NHLBI Family Heart Study: objectives and design. Am J Epidemiol. 1996;143:1219–1228[Abstract/Free Full Text]
  33. Higgins M. Epidemiology and prevention of coronary heart disease in families. Am J Med. 2000;108:387–395[CrossRef][Web of Science][Medline]
  34. Pankow JS, Folsom AR, Province MA. Family history of coronary heart disease and hemostatic variables in middle-aged adults. Atherosclerosis Risk in Communities Investigators and Family Heart Study Research Group. Thromb Haemost. 1997;77:87–93[Web of Science][Medline]
  35. King RC, Stansfield WD. A Dictionary of Genetics. New York: Oxford University Press; 1997.
  36. US Surgeon General, Reducing the Health Consequences of Smoking
  37. Genest JJ, Martin-Munley S, McNamara J. Familial lipoprotein disorders in patients with premature coronary heart disease. Circulation. 1992;85:2025–2033[Abstract/Free Full Text]
  38. Williams RR, Hamilton-Craig I, Kostner GM. MED-PED. An integrated genetic strategy for preventing early deaths. Berg K, Boulyjenkov V, Christen Y. Genetic Approaches to Noncommunicable Diseases. Berlin, Heidelburg: Springer-Verlag; 1996.
  39. Goble A, Jackson B, Phillips P, Race E, Oliver RG, Worcester MC. The Family Atherosclerosis Risk Intervention Study (FARIS): risk factor profiles of patients and their relatives following an acute cardiac event. Aust NZ J Med. 1997;27:568–577[Web of Science][Medline]
  40. Knutsen SF, Knutsen R. The Tromso Survey: the Family Intervention study—the effect of intervention on some coronary risk factors and dietary habits, a 6-year follow-up. Prev Med. 1991;20:197–212[CrossRef][Web of Science][Medline]
  41. Pyke SD, Wood DA, Kinmonth AL, Thompson SG. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The British Family Heart Study. Arch Fam Med. 1997;6:354–360[Abstract/Free Full Text]
  42. Doyle AC. The Sign of Four. New York: Doubleday and Company; 1930.
  43. Higgins M, Thom T, Blackburn H. Atherome dans le monde. Realites Cardiologiques. 1998;123:
  44. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547–1557[CrossRef][Web of Science][Medline]
  45. Kuulasmaa K, Tunstall-Pedoe H, Dobson A. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675–687[CrossRef][Web of Science][Medline]
  46. Tunstall-Pedoe H, Vanuzzo D, Hobbs M. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000;355:688–700[CrossRef][Web of Science][Medline]
  47. Hunink MG, Goldman L, Tosteson AN. The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277:535–542[Abstract/Free Full Text]
  48. National Center for Health Statistics, Health United States 1998 with Socioeconomic Status and Health Chartbook, Hyattsville, MD, Department of Health and Human Services, 1998
  49. Stengard J, Weiss K, Sing C. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet. 1998;103:234–241[CrossRef][Web of Science][Medline]
  50. Stengard JH, Kardia SL, Tervahauta M, Ehnholm C, Nissinen A, Sing C. Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by Apo E genotype and area of residence. Clin Genet. 1999;56:367–377[CrossRef][Web of Science][Medline]
  51. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000;342:1–8[Abstract/Free Full Text]
  52. Stone E, Pearson T, Fortmann S. Community-based prevention trials: Challenges and directions for public health practice, policy, and research. Ann Epidemiol. 1997;S7:S113–120
  53. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322–1327[Abstract/Free Full Text]
  54. Gotto AM, Whitney E, Stein EA. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study. Eur Heart J. 2000;21:1627–1633[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
J De Sutter, D De Bacquer, K Kotseva, S Sans, K Pyorala, D Wood, G De Backer, and on behalf of the EUROASPIRE II study group
Screening of family members of patients with premature coronary heart disease: Results from the EUROASPIRE II family survey
Eur. Heart J., February 1, 2003; 24(3): 249 - 257.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Higgins, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higgins, M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?